Dr. Nadine Abi-Jaoudeh and Dr. Nicholas J. Petruzzi discuss "Comparison of three chemoembolization regimens for hepatocellular carcinoma: adriamycin and ethiodol has shorter time to progression than cisplatin/adriamycin/mitomycin-C and ethiodol or adriamycin drug eluting beads".